The Aligarh Muslim University’s Jawaharlal Nehru Medical College (JNMC) will soon start convalescent plasma therapy for the treatment of COVID-19 patients with moderate disease. In this connection, AMU Vice-Chancellor Tariq Mansoor has approved the purchase of a plasma machine at the cost of ₹29 lakhs.
Agra’s S.N. Medical College and Government Institute of Medical Sciences, Greater Noida, are already using the therapy to treat infected patients in the region.
Declared as a dedicated COVID facility by the State government to treat severe virus patients, so far, over 40, 000 samples have been tested with the two RT-PCR Thermo Fisher machines installed at JNMC.
More than 800 samples from Aligarh, Mathura, Noida, Kasganj, Hathras, Bulandshahar, Agra, Rampur, and Etah are tested every day.Various departments of JNMC are also running tele-medical facilities for non-COVID-19 patients, said an official release.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath